Eric Francis Yves Thepaut - 16 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Pres, Eur, Mid-East, Afr
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2024
Net transactions value
-$181,597
Form type
4
Filing time
20 Feb 2024, 21:05:14 UTC
Previous filing
11 Mar 2024
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,263 +8.3% $0.000000 29,461 16 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $86,290 -1,311 -4.4% $65.82 28,150 16 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +2,500 +8.9% $0.000000 30,650 17 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $95,307 -1,448 -4.7% $65.82 29,202 17 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -2,263 -33% $0.000000 4,526 16 Feb 2024 Common Stock 2,263 Direct F1, F2
transaction BSX Restricted Stock Units Options Exercise $0 -2,500 -50% $0.000000 2,500 17 Feb 2024 Common Stock 2,500 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.